NCT00343070

Functional Neuroimaging in Depression

Functional Neuroimaging in Depression: Longitudinal Study of PET Metabolism in Correlation With Changes in Attentional Bias, Autobiographical Memory, Future Fluency and Facial Recognition in Depressed Patients Treated With Escitalopram.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University Hospital, Ghent · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Oral administration of escitalopram during 8 weeks; PET scan with 18F-FDG at inclusion and after 8 weeks

Conditions

• Major Depression

Interventions

Type	Name	Description
DRUG	Oral administration of escitalopram during 8 weeks

Timeline

• Start date: 2007-03-01
• Primary completion: 2009-10-01
• Completion: 2009-10-01
• First posted: 2006-06-22
• Last updated: 2010-08-31

Locations

2 sites across 1 country: Belgium